SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (661)6/18/2004 10:18:32 AM
From: tuck  Read Replies (1) of 897
 
Indeed, the night time glucose measurement is not mentioned in the recently touted data from two extension studies by NKTR/Pfizer. I think someone in the AC is going to ask about this issue, and send 'em back for the data. Maybe give them an approvable letter, requiring a PIV as the most favorable outcome. A ML analyst has voiced similar concerns now, as well as concerns that the filing and launch could be delayed yet again.

So shorting NKTR here, a full position at $18.55.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News